Trial
NCT02337478
Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Wake Forest University Health Sciences
Collaborators
National Cancer Institute (NCI); Spectrum Pharmaceuticals, Inc
Condition
Recurrent Adult Acute Myeloid Leukemia
Intervention
Vincristine Sulfate Liposome
Why stopped
The study was stopped early due to futility.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-08-14